<?xml version="1.0" encoding="UTF-8"?>
<p>Today, reverse transcription polymerase chain reaction (RT‐PCR) is the COVID‐19 diagnostic test.
 <xref rid="cld973-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref>, 
 <xref rid="cld973-bib-0007" ref-type="ref">
  <sup>7</sup>
 </xref> RT‐PCR sensitivity is highest for testing bronchial alveolar lavage fluid (93%) and declines for sputum (72%) and nasal swab (63%) specimens.
 <xref rid="cld973-bib-0010" ref-type="ref">
  <sup>10</sup>
 </xref> COVID‐19 diagnosis might require repeat testing.
 <xref rid="cld973-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref>, 
 <xref rid="cld973-bib-0007" ref-type="ref">
  <sup>7</sup>
 </xref> Serological tests to detect SARS‐CoV‐2 IgM and IgG antibodies are available. However, because of test sensitivity and other quality concerns, the US Food and Drug Administration (FDA; 
 <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov</ext-link>) advises current serological tests are best used for surveillance and research, and not as the sole basis for COVID‐19 diagnosis.
</p>
